![Nam-Chun Cho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nam-Chun Cho
Private Equity Investor bei
Aju IB Investment Co., Ltd. (Private Equity)
Profil
Mr. Nam-Chun Cho is Executive Director at Aju IB Investment Co., Ltd.
Previously he worked at Korea Investors Services, Inc.
He graduated Kyunghee University.
Aktive Positionen von Nam-Chun Cho
| Unternehmen | Position | Beginn |
|---|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Private Equity Investor | 01.01.2008 |
Ehemalige bekannte Positionen von Nam-Chun Cho
| Unternehmen | Position | Ende |
|---|---|---|
| OSANG HEALTHCARE CO.,LTD | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
Osang Healthcare Co., Ltd.
 Osang Healthcare Co., Ltd. Medical SpecialtiesHealth Technology Develops blood glucose & biochemical meters and immunodiagnostic systems | Health Technology |
Wählen Sie MarketScreener 
